BioAge Labs
The AI engine Fit Assessment
BetaBioAge is a biotechnology company focused on discovering and developing therapeutics to address aging and related diseases. Their mission is to extend healthy lifespan by targeting the molecular causes of aging through a diverse portfolio of drugs.
Blurb
BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.
HQ Location
Richmond (United States)
Founded
2015
Employees
51 - 200
Total funding raised
$908.91M
Last Funding Event
IPO, $615.01M, September 26, 2024
Smart insights
- 1Y headcount growth: 11%
- Headcount-to-last-round ratio: 3.9 employees/$M
BIOAGE discovers and develops drugs to treat aging and associated diseases. The company's primary initiative, azelaprag, is an oral APJ agonist on track for Phase 2 trials in conjunction with tirzepatide to potentially become a groundbreaking treatment for obesity in the elderly.